An unusual case of autoimmune hemolytic anemia with reticulocytopenia, erythroid dysplasia, and an IgG2 autoanti-U

Transfusion

Volumn 36, Issue 6, 1996, Pages 575-580

  Roush, G R ^a   Rosenthal, N S ^b,c   Gerson, S L ^b,c   Toy, E M ^d   Mccarthy, P ^e   Hirschler, N V ^b,e,f   Yomtovian, R ^b,c  

^a ST ELIZABETH HEALTH CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d Timken Mercy Medical Center   (United States)

^e AMERICAN RED CROSS   (United States)

^f Blood Centers of the Pacific   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; ERYTHROCYTE ANTIBODY; IMMUNOGLOBULIN G2;

ADULT; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; HUMAN; MALE; MYELODYSPLASIA; RETICULOCYTE; TREATMENT OUTCOME;

EID: 0030062213     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36696269519.x     Document Type: Article

References (60)

1. Nugent ME, Colledge KI, Marsh WL. Auto-immune hemolytic anemia caused by anti-U. Vox Sang 1971;20:519-25.
2. Marsh WL, Reid ME, Scott EP. Autoantibodies of U blood group specificity in autoimmune hemolytic anaemia. Br J Haematol 1972;22:625-9.
3. Vos GH, Petz LD, Garratty G, Fundenberg HH. Autoantibodies in acquired hemolytic anemia with special reference to the LW system. Blood 1973;42:445-53.
4. b, and other autoantibodies responsible for positive direct antiglobulin tests in 150 individuals. Br J Haematol 1976;34:5-18.
5. Bindon CI, Hale G, Bruggemann M, Waldmann H. Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q. J Exp Med 1988;168:127-42.
6. Ravetch JV, Kinet JP. Fc receptors. Annu Rev Immunol 1991;9:457-92.
7. Rosse WF. Clinical immunohematology: basic concepts and clinical applications. Boston: Blackwell, 1990:107-41.
8. Edwards JM, Moulds JJ, Judd WJ. Chloroquine dissociation of antigen-antibody complexes: a new technique for typing red blood cells with a positive direct antiglobulin test. Transfusion 1982;32:59-61.
9. Immunohematology methods and procedures. 1st ed. Rockville, MD: American Red Cross National Reference Laboratory, 1993:23.1.
10. Nance S, Garratty G. A new potentiator of red blood cell antigen-antibody reactions. Am J Clin Pathol 1987;87:633-5.
11. Postoway N, Garratty G. Standardization of IgG subclass antiserums for use with sensitized red cells. Transfusion 1983;23:398-9.
12. Marsh WL. Scoring of hemagglutination reactions. Transfusion 1972;12:352-3.
13. Branch DR, Petz LD. A new reagent (ZZAP) having multiple applications in immunohematology. Am J Clin Pathol 1982;78:161-7.
14. Nance SJ, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:449-52.
15. Garratty G. Predicting the clinical significance of red cell antibodies with in vitro cellular assays. Transfus Med Rev 1990;4:297-312.
16. Walker RH, ed. Technical manual. 11th ed. Bethesda: American Association of Blood Banks, 1993.
17. Garratty G. Laboratory investigation of drug-induced immune hemolytic anemia. In: Bell CA, ed. A seminar on laboratory management of hemolysis (supplement). Washington: American Association of Blood Banks, 1979.
18. Judd JW. Methods in immunohematology. 2nd ed. Durham, NC: Montgomery Scientific Publications, 1994
19. Garratty G. Target antigens for red-cell-bound autoantibodies. In: Nance ST, ed. Clinical and basic science aspects of immunohematology. Arlington: American Association Blood Banks, 1991:33-72.
20. Salmon C, Cartron JP, Rouger P, eds. The human blood groups. Paris: Masson Publishing, 1984:259-87.
21. null. Transfusion 1967;7:33-4.
22. Pillay GS, Womack B, Sandler SG. Immune-mediated hemolysis in a postoperative patient. Case report: anti-U and differential diagnosis. Immunohematology 1993;9:41-6.
23. Dopp SL, Isham BE. Anti-U and hemolytic disease of the newborn (letter). Transfusion 1983;23:273-4.
24. Garratty G. Factors affecting the pathogenicity of red cell auto- and alloantibodies. In: Nance SJ, ed. Immune destruction of red blood cells. Arlington: American Association of Blood Banks, 1989:109-69.
25. Nance S, Bourdo S, Garratty G. IgG2 red cell sensitization associated with autoimmune hemolytic anemia (abstract). Transfusion 1983;23:413.
26. Abramson N, Gelfand EW, Jandl JH, Rosen FS. The interaction between human monocytes and red cells. Specificity for IgG subclasses and IgG fragments. J Exp Med 1970;132:1207-15.
27. Burton DR. Immunoglobulin G: functional sites. Mol Immunol 1985;22:161-206.
28. Alexander MD, Andrews JA, Leslie RG, Wood NJ. The binding of human and guinea-pig IgG subclasses to homologous macrophage and monocyte Fc receptors. Immunology 1978;35:115-23.
29. Unkeless JC, Scigliano E, Freedman VH. Structure and function of human and murine receptors for IgG. Annu Rev Immunol 1988;6:251-81.
30. Dangl JL, Wensel TG, Morrison SL, et al. Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. EMBO J 1988;7:1989-94.
31. Bruggemann M, Williams GT, Bindon CI, et al. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med 1987;166:1351-61.
32. Horsewood P, Kelton JG. Macrophage-mediated cell destruction. In: Garratty G, ed. Immunobiology of transfusion medicine. New York: Marcel Dekker, 1994:435-64.
33. Zupanska B. Cellular immunoassays and their use for predicting the clinical significance of antibodies. In: Garratty G, ed. Immunobiology of transfusion medicine. New York: Marcel Dekker, 1994:465-91.
34. DeCoteau J, Reis MD, Pinkerton PH, et al. Positive antiglobulin test in association with sulindac: involvement of the Rh factor. Vox Sang 1993;64:179-83.
35. Squires JE, Mintz PD, Clark S. Tolmetin-induced hemolysis. Transfusion 1985;25:410-3.
36. Johnson FP Jr, Hamilton HE, Liesch MR. Immune hemolytic anemia associated with sulindac. Arch Intern Med 1985;145:1515-6.
37. Schulenburg BJ, Beck ML, Pierce SR, et al. Immune hemolysis associated with Zomax (abstract). Transfusion 1983;23:409.
38. Salama A, Mueller-Eckhardt C, Kissel K, et al. Ex vivo antigen preparation for the serological detection of drug-dependent antibodies in immune haemolytic anaemias. Br J Haematol 1984;58:525-31.
39. Petz LD. Drug-induced immune hemolysis (editorial). N Engl J Med 1985;313:510-2.
40. Petz LD. Drug-induced autoimmune hemolytic anemia. Transfus Med Rev 1993;7:242-54.
41. Garratty G. Drug-induced immune hemolytic anemia. In: Garratty G, ed. Immunobiology of transfusion medicine. New York: Marcel Dekker, 1994:523-51.
42. Hegde UM, Gordon-Smith EC, Worlledge SM. Reticulocytopenia and absence of red cell autoantibodies in immune haemolytic anaemia. Br Med J 1977;2:1444-7.
43. Cazzola M, Barosi G, Ascari E. Cold haemagglutinin disease with severe anaemia, reticulocytopenia and erythroid bone marrow. Scand J Haematol 1983;30:25-9.
44. Mangan KF, Besa EC, Shadduck RK, et al. Demonstration of two distinct antibodies in autoimmune hemolytic anemia with reticulocytopenia and red cell aplasia. Exp Hematol 1984;12:788-93.
45. Shichiri M, Koyama W, Tozuka S, et al. Primary biliary cirrhosis. A patient with adverse reactions to tiopronin and autoimmune hemolytic anemia with reticulocytopenia. Arch Intern Med 1984;144:89-91.
46. Liesveld JL, Rowe JM, Lichtman MA. Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases. Blood 1987;69:820-6.
47. Crosby WH, Rappaport H. Reticulocytopenia in autoimmune hemolytic anemia. Blood 1956;11:929-36.
48. Greenberg J, Curtis-Cohen M, Gill FM, Cohen A. Prolonged reticulocytopenia in autoimmune hemolytic anemia of childhood. J Pediatr 1980;97:784-6.
49. Conley CL, Lippman SM, Ness P. Autoimmune hemolytic anemia with reticulocytopenia. A medical emergency. JAMA 1980;244:1688-90.
50. Conley CL, Lippman SM, Ness P, et al. Autoimmune hemolytic anemia with reticulocytopenia and erythroid marrow. N Engl J Med 1982;306:281-6.
51. Taniguchi S, Shibuya T, Morioka E, et al. Demonstration of three distinct immunological disorders on erythropoiesis in a patient with pure red cell aplasia and autoimmune haemolytic anaemia associated with thymoma. Br J Haematol 1988;68:473-7.
52. Gahmberg CG, Jokinen M, Andersson LC. Expression of the major sialoglycoprotein (glycophorin) on erythroid cells in human bone marrow. Blood 1978;52:379-87.
53. Issitt PD. Applied blood group serology. 3rd ed. Miami: Montgomery Scientific Publications, 1985:532-70.
54. Petz LD. Transfusing the patient with autoimmune hemolytic anemia. Clin Lab Med 1982;2:193-210.
55. Rosenfield RE, Jagathambal. Transfusion therapy for autoimmune hemolytic anemia. Semin Hematol 1976;13:311-21.
56. Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. 9th ed. Oxford: Blackwell, 1993:283-320.
57. Sokol RJ, Hewitt S, Booker DJ, Morris BM. Patients with red cell autoantibodies: selection of blood for transfusion. Clin Lab Haematol 1988;10:257-64.
58. Salama A, Berghöfer H, Mueller-Eckhardt C. Red blood cell transfusion in warm-type autoimmune haemolytic anaemia. Lancet 1992;340:1515-7.
59. Buchanan GR, Boxer LA, Nathan DG. The acute and transient nature of idiopathic immune hemolytic anemia in childhood. J Pediatr 1976;88:780-3.
60. Dausset J, Colombani J. The serology and prognosis of 128 cases of autoimmune hemolytic anemia. Blood 1959;14:1280-301.